Parathyroid Hormone Secretory Response to EDTA-Induced Hypocalcemia in Black and White Premenopausal Women F. CosmanJ. NievesR. Lindsay OriginalPaper 06 March 2014 Pages: 257 - 261
Vitamin D Binding Protein Gene in Male Osteoporosis: Association of Plasma DBP and Bone Mineral Density with (TAAA)n-Alu Polymorphism in DBP S. S. PapihaL. C. AllcroftH. K. Datta OriginalPaper 06 March 2014 Pages: 262 - 266
Prednisolone Induces an Increase in Serum Calcium Concentration: Possible Involvement of the Kidney, the Bone, and the Intestine K. YonemuraA. HishidaH. Kumagai OriginalPaper 06 March 2014 Pages: 267 - 271
Effects of Promethazine on Bone Mass and on Bone Remodeling in Ovariectomized Rats: A Morphometric, Densitometric, and Histomorphometric Experimental Study H. RicoM. GómezJ. J. Gervás OriginalPaper 06 March 2014 Pages: 272 - 275
Inhibition of Chondrocyte Terminal Differentiation and Matrix Calcification by Soluble Factors Released by Articular Chondrocytes A. JikkoY. KatoH. Fuchihata OriginalPaper 06 March 2014 Pages: 276 - 279
Computer-Assisted 3D Reconstruction of Serial Sections of Cortical Bone to Determine the 3D Structure of Osteons S. D. StoutB. S. BrunsdenN. C. Tappen OriginalPaper 06 March 2014 Pages: 280 - 284
The Effect of Vitamin K and D Supplementation on Ovariectomy-Induced Bone Loss S. MatsunagaH. ItoT. Sakou OriginalPaper 06 March 2014 Pages: 285 - 289
Vitamin D and the D-Hormones, Alfacalcidol and Calcitriol, as Therapeutic Agents for Osteoporotic Populations L. V. Avioli Editorial 06 March 2014 Pages: 292 - 294
Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) Therapy K.-H. W. LauD. J. Baylink OriginalPaper 06 March 2014 Pages: 295 - 306
The Special Role of ``Hormonal'' Forms of Vitamin D in the Treatment of Osteoporosis B. E. C. NordinA. G. NeedM. Horowitz OriginalPaper 06 March 2014 Pages: 307 - 310
The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis A. ShiraishiS. HigashiE. Ogata OriginalPaper 06 March 2014 Pages: 311 - 316
Rationale for Treatment of Involutional Osteoporosis in Women and for Prevention and Treatment of Corticosteroid-Induced Osteoporosis with Alfacalcidol E. Schacht OriginalPaper 06 March 2014 Pages: 317 - 327
Alphacalcidol in Prevention of Glucocorticoid-Induced Osteoporosis J. Y. ReginsterC. de FroidmontJ.-O. Defraigne OriginalPaper 06 March 2014 Pages: 328 - 331
Calcium and Vitamin D Therapy in Corticosteroid-Induced Bone Loss: What is the Evidence? J. D. AdachiG. Ioannidis OriginalPaper 06 March 2014 Pages: 332 - 336
Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium J. D. RingeA. CösterR. Umbach OriginalPaper 06 March 2014 Pages: 337 - 340
Alfacalcidol and Calcitriol in the Prevention of Bone Loss after Organ Transplantation P. Sambrook OriginalPaper 06 March 2014 Pages: 341 - 343
